Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathwayHong Ki Min, Kyoung‐Woon Kim|Arthritis Research & Therapy|2020Cited by 36
Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance dataHong Ki Min, Jong Heon Park, Ho Jin Jeong et al.|Epidemiology and Health|2023Cited by 23
Interleukin (IL)-25 suppresses IL-22 induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathwayHong Ki Min, Kyoung‐Woon Kim|Research Square|2019Cited by 0
Interleukin (IL)-25 suppresses IL-22 induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathwayHong Ki Min, Kyoung‐Woon Kim|Research Square|2020Cited by 0